Fresenius Medical Care AG
FMS
$22.08
-$0.03-0.11%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -64.58% | 18.51% | 25.66% | 60.66% | 123.15% |
| Total Depreciation and Amortization | 17.34% | -17.35% | 1.93% | 2.05% | 11.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.56% | 700.09% | 121.92% | -824.38% | -91.10% |
| Change in Net Operating Assets | -330.84% | 72.04% | -67.66% | 178.95% | -274.99% |
| Cash from Operations | -77.67% | 34.50% | -1.42% | 413.28% | -80.67% |
| Capital Expenditure | 55.71% | -119.13% | -28.25% | -14.23% | 40.21% |
| Sale of Property, Plant, and Equipment | -39.99% | 1,588.35% | -96.10% | 145.23% | -54.98% |
| Cash Acquisitions | -236.30% | 205.95% | 64.77% | -60.47% | -133.56% |
| Divestitures | -96.08% | -73.26% | 13,357.32% | -93.73% | -85.38% |
| Other Investing Activities | 148.22% | -1,586.77% | -120.33% | -36.30% | 165.70% |
| Cash from Investing | 60.05% | -671.10% | 60.84% | -41.54% | 10.35% |
| Total Debt Issued | -65.27% | 585.06% | -93.41% | 937.82% | 239.16% |
| Total Debt Repaid | 10.81% | 68.66% | -21.96% | -199.69% | 75.68% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 20.00% | -187.30% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 100.00% | -- | -- |
| Other Financing Activities | -20.89% | 84.22% | -736.02% | 24.00% | 53.03% |
| Cash from Financing | -106.30% | 81.72% | -1,576.15% | 161.56% | 85.80% |
| Foreign Exchange rate Adjustments | 157.32% | -97.57% | 76.36% | -239.64% | -143.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -203.49% | 173.60% | -174.50% | 748.72% | 47.85% |